The chemical and biochemical consequences of the binding of the antitumour drug cisplatin and other platinum group metal complexes to DNA

Cet article presente un ensemble de travaux concernant la preparation et la caracterisation structurale de complexes du platine (II) et d'autres platinoides avec des nucleotides et avec l'ADN. Presentation des etudes immunochimiques des composes de coordination avec l'ADN

[1]  B. Hill,et al.  Possible mechanism for differences in sensitivity to cis-platinum in human prostate tumor cell lines. , 1986, Cancer letters.

[2]  R. Ozols,et al.  Quantitation of cis-diamminedichloroplatinum II (cisplatin)-DNA-intrastrand adducts in testicular and ovarian cancer patients receiving cisplatin chemotherapy. , 1986, The Journal of clinical investigation.

[3]  M. Foka,et al.  Interaction of cis-diamminedichloroplatinum (II) to chromatin. Specificity of the drug distribution. , 1986, Biochemical pharmacology.

[4]  J. Butour,et al.  Chemical reactivity of monofunctional platinum-DNA adducts. , 1986, Biochemistry.

[5]  P. Lohman,et al.  Formation and repair of DNA interstrand cross-links in relation to cytotoxicity and unscheduled DNA synthesis induced in control and mutant human cells treated with cis-diamminedichloroplatinum(II). , 1985, Cancer research.

[6]  E. Alessio,et al.  Chemical properties of rare platinum metal complexes having antitumor activity , 1987 .

[7]  H. C. Harder,et al.  Inhibitory effects of anti‐tumor platinum compounds on DNA, RNA and protein syntheses in mammalian cells in vitro , 1970, International journal of cancer.

[8]  M. Marinus,et al.  Mismatch repair of cis-diamminedichloroplatinum(II)-induced DNA damage. , 1985, Molecular pharmacology.

[9]  F. M. Sinex,et al.  Specific binding of antitumour drug cis-Pt(NH3)2Cl2 to DNA rich in guanine and cytosine , 1974, Nature.

[10]  L. Marzilli,et al.  Novel, definitive NMR evidence for N(7), .alpha.PO4 chelation of 6-oxopurine nucleotide monophosphates to platinum anticancer drugs , 1986 .

[11]  S. Feldman,et al.  Further characterization of the platinum-reactive component of the alpha 2-macroglobulin-receptor recognition site. , 1986, The Biochemical journal.

[12]  H. Elst,et al.  The antitumor drug cis-diamminedichloroplatinum(II) preferentially chelating neighboring guanines in the trinucleotide d(pGpGpG) , 1987 .

[13]  S. Crooke,et al.  Effects of second-generation platinum analogs on isolated PM-2 DNA and their cytotoxicity in vitro and in vivo. , 1980, Cancer research.

[14]  P. Sadler,et al.  The structure of the antitumor complex cis-(diammino) (1,1-cyclobutanedicarboxylato)-Pt(II): X ray and nmr studies , 1980 .

[15]  J. Reedijk,et al.  Intrastrand bis(guanine) chelation of trinucleoside diphosphate d(CpGpG) to cis-platinum: an x-ray single-crystal structure analysis , 1987 .

[16]  T. Theophanides,et al.  FT-IR Spectroscopic evidence of sugar ring conformational changes in GpC and CpG on platination and intercalation , 1987 .

[17]  L. Marzilli,et al.  Evidence for similar structural changes on binding of platinum anti‐tumor agents to DNA and nucleosomes , 1984, FEBS letters.

[18]  A. Eastman.  Interstrand cross-links and sequence specificity in the reaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. , 1985, Biochemistry.

[19]  R. Martin,et al.  Nucleoside sites for transition metal ion binding , 1985 .

[20]  J. Lipiński.  Electronic structure of platinum(II) antitumor complexes and their interactions with nucleic acid bases. I , 1988 .

[21]  C. Monti-Bragadin,et al.  Effects of cis-Dichlorodiammineplatinum (II) and Related Transition Metal Complexes on Escherichia coli , 1975, Antimicrobial Agents and Chemotherapy.

[22]  A. Eastman,et al.  The significance of DNA cross-linking to cis-diamminedichloroplatinum(II)-induced cytotoxicity in sensitive and resistant lines of murine leukemia L1210 cells. , 1982, Chemico-biological interactions.

[23]  D. Mentzafos,et al.  Trichloro(9-methylguaninium)platinum(II) hydrate and 9-methylguaninium hexachloroplatinate(IV) dihydrate: synthesis and structure , 1983 .

[24]  A. Eastman.  Reevaluation of interaction of cis-dichloro(ethylenediamine)platinum(II) with DNA. , 1986, Biochemistry.

[25]  A. Marcelis,et al.  Conformational analysis of the adduct cis-[Pt(NH3)2 d(GpG)]+ in aqueous solution. A high field (500-300 MHz) nuclear magnetic resonance investigation. , 1982, Nucleic acids research.

[26]  S. Rešlová,et al.  The induction of lysogenic strains of Escherichia coli by cis-dichloro-diammineplatinum (II). , 1971, Chemico-biological interactions.

[27]  H. Peresie,et al.  Heavy transition metal complexes of biologically important molecules. 3. Crystal and molecular structure of bis(.mu.-1-methylthyminato-N3,O4)bis(cis-diammineplatinum(II)) dinitrate hydrate, [(NH3)2Pt(C6H7N2O2)2Pt(NH3)2](NO3)2.H2O , 1978 .

[28]  T. Theophanides,et al.  FT-IR and 1H NMR spectroscopic studies of C2′- endo, C3′-endo sugar ring conformations in 5′-GMP and 3′-GMP nucleotides and their platinum complexes , 1986 .

[29]  R. Bau,et al.  Structure of bis[ethylenediamine(5'-cytidine monophosphate)platinum] dihydrate. An example of direct platinum-phosphate bonding , 1977 .

[30]  K. Kohn,et al.  Kinetics of formation and disappearance of a DNA cross-linking effect in mouse leukemia L1210 cells treated with cis- and trans-diamminedichloroplatinum(II). , 1978, Cancer research.

[31]  D. Fairlie,et al.  A 195Pt and 15N N.M.R. study of the anticancer drug, cis-diammine-dichloroplatinum(II), and its hydrolysis and oligomerization products , 1981 .

[32]  G. Zon,et al.  31P NMR investigation of fourteen self-complementary oligodeoxyribonucleotides (8-mer to 14-mer) treated with platinum complexes: the downfield 31P NMR signal characteristic of anti-cancer drugs is observed only for molecules with adjacent G residues , 1987 .

[33]  B. James,et al.  Ruthenium (II) halide dimethylsulphoxide complexes from hydrogenation reactions , 1971 .

[34]  B. Rosenberg.  Platinum complex-DNA interactions and anticancer activity , 1978 .

[35]  K. Kohn,et al.  DNA cross-linking as an indicator of sensitivity and resistance of mouse L1210 leukemia to cis-diamminedichloroplatinum(II) and L-phenylalanine mustard. , 1981, Cancer research.

[36]  J. Le Pecq,et al.  Role of ligand exchange processes in the reaction kinetics of the antitumor drug cis-diamminedichloroplatinum(II) with its targets. , 1985, Cancer research.

[37]  D. Alberts,et al.  Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. , 1978, The New England journal of medicine.

[38]  J. Drobník,et al.  The effect of cis-dichlorodiammineplatinum(II) on Escherichia coli B. The role of fil, exr and hcr markers. , 1973, Mutation research.

[39]  A. Kelman,et al.  Platinum-DNA crosslinking: platinum antitumor drug interactions with native lambda bacteriophage DNA studied using a restriction endonuclease , 1978 .

[40]  L. Zwelling,et al.  DEFECTIVE MONOCYTE KILLING IN PATIENTS WITH MALIGNANCIES AND RESTORATION OF FUNCTION DURING CHEMOTHERAPY , 1980, The Lancet.

[41]  P. Lohman,et al.  Detection and quantification of adducts formed upon interaction of diamminedichloroplatinum (II) with DNA, by anion-exchange chromatography after enzymatic degradation. , 1982, Nucleic acids research.

[42]  S. Crooke,et al.  Use of covalently closed circular deoxyribonucleic acid for prescreening for antitumor compounds , 1979, Antimicrobial Agents and Chemotherapy.

[43]  L. Zwelling,et al.  Enhancement of naturally occurring human spontaneous monocyte-mediated cytotoxicity by cis-diamminedichloroplatinum(II). , 1980, Cancer research.

[44]  A. van der Eb,et al.  Adenovirus: transformation and oncogenicity. , 1984, Biochimica et biophysica acta.

[45]  J. Vollano,et al.  Interaction of the antitumor agents cis,cis,trans-PtIV(NH3)2Cl2(OH)2 and cis,cis,trans-PtIV[(CH3)2CHNH2]2Cl2(OH)2 and their reduction products with PM2 DNA. , 1984, Biochemistry.

[46]  S. Lippard,et al.  Metal binding by thionucleosides. , 1972, Journal of the American Chemical Society.

[47]  J. H. Boom,et al.  Alteration of bleomycin cleavage specificity in a platinated DNA oligomer of defined structure , 1988 .

[48]  I. Ismail,et al.  Kinetic studies on the diaqua form of cis-platin and various nucleobases. , 1985, Journal of inorganic biochemistry.

[49]  K. Kohn,et al.  DNA-protein and DNA interstrand cross-linking by cis- and trans-platinum(II) diamminedichloride in L1210 mouse leukemia cells and relation to cytotoxicity. , 1979, Cancer research.

[50]  F. Rochon,et al.  Crystal structure of a hydroxo-bridged platinum(II) tetramer, cyclotetrakis(.mu.-hydroxo)tetrakis((ethylenediamine)platinum(II)) tetranitrate , 1988 .

[51]  T. Huynh-Dinh,et al.  DNA fragment conformations. A 1H-NMR conformational analysis of the d(G-G)-chelated platinum-oligonucleotide d(A-T-G-G)cisPt. , 1984, European journal of biochemistry.

[52]  F. Friedlos,et al.  Inherent sensitivity of cultured human embryonal carcinoma cells to adducts of cis-diamminedichloroplatinum(II) on DNA. , 1987, Cancer research.

[53]  E. Holler,et al.  Effects of coordination of diammineplatinum(II) with DNA on the activities of Escherichia coli DNA polymerase I. , 1988, Biochemistry.

[54]  D. Mansuy,et al.  Interaction of cis-diaquodiammineplatinum dinitrate with ribose dinucleoside monophosphates , 1980 .

[55]  P. Lohman,et al.  Induction and repair of DNA cross-links in chinese hamster ovary cells treated with various platinum coordination compounds in relation to platinum binding to DNA, cytotoxicity, mutagenicity, and antitumor activity. , 1984, Cancer research.

[56]  A. Laoui,et al.  cis-Diamminediaquaplatinum(II) selectivity for GpG: influence of the adjacent base on the first platination step , 1988 .

[57]  R. Hoffmann.  The effect of cisplatin and platinum(IV)chloride on cell growth, RNA, protein, ribosome and DNA synthesis in yeast , 1988 .

[58]  A. Robins.  The reaction of 14 C-labelled platinum ethylenediamine dichloride with nucleic acid constituents. , 1973, Chemico-biological interactions.

[59]  T. Appleton,et al.  Multinuclear NMR study of reactions of methylphosphonic acid, CH3PO3H2, and (aminoalkyl)phosphonic acids, NH2(CH2)nPO3H2 (n = 1-3), with the cis-diamminediaquaplatinum(II) cation and cis-diamminedihydroxoplatinum(II) , 1986 .

[60]  S. Crooke,et al.  Characterization of in vitro deoxyribonucleic acid breakage and cross-linking induced by bis-isopropylamine)-trans-dihydroxy-cis-dichloroplatinum(IV). , 1982, Biochemistry.

[61]  S. Livingstone,et al.  Metal chelates of biologically important compounds. I. Complexes of DL-ethionine and S-methyl-L-cysteine , 1968 .

[62]  A. Kraker,et al.  Accumulation of cis-diamminedichloroplatinum(II) and platinum analogues by platinum-resistant murine leukemia cells in vitro. , 1988, Cancer research.

[63]  D. Fairlie,et al.  cis-Platinum(II) amine complexes: some structure-activity relationships for immunosuppressive, nephrotoxic and gastrointestinal (side) effects in rats. , 1980, Chemico-biological interactions.

[64]  S. Lippard.  Chemistry and molecular biology of platinum anticancer drugs , 1987 .

[65]  H. C. Harder,et al.  Coordination of interstrand cross-links between polydeoxyguanylic acid and polydeoxycytidylic acid by cis-diamminedichloroplatinum (II). , 1983, Cancer research.

[66]  T. Theophanides,et al.  An FT-IR and 1H NMR spectral study of sugar ring conformations in guanosine and in several platinum(II) complexes , 1986 .

[67]  R. Brubaker,et al.  Mutagenic properties of cis-plantinum(II)diammino-dichloride in Escherichia coli. , 1975, Mutation research.

[68]  J. Vollano,et al.  Comparative antitumor studies on platinum(II) and platinum(IV) complexes containing 1,2-diaminocyclohexane. , 1987, Journal of medicinal chemistry.

[69]  P. Tofilon,et al.  cis-Diamminedichloroplatinum(II)-induced sister chromatid exchange: an indicator of sensitivity and heterogeneity in primary human tumor cell cultures. , 1986, Cancer research.

[70]  J. Roberts,et al.  Excision repair of cis-diamminedichloroplatinum(II)-induced damage to DNA of Chinese hamster cells. , 1979, Cancer research.

[71]  A. Beauchamp,et al.  N7/06 chelation in a complex with an analog of guanine. Preparation, spectroscopic study, and crystal structure of bis(.eta.5-cyclopentadienyl)(theophyllinato)titanium(III) , 1986 .

[72]  J. Vollano,et al.  DNA Breakage by a Perhydrate Complex of cis, cis, trans -PtIVCl2(NH3)2(OH)2 , 1984 .

[73]  J. Roberts,et al.  Interactions between mammalian cell DNA and inorganic platinum compounds. II. Interstrand cross-linking of isolated and cellular DNA by platinum(IV) compounds. , 1974, Biochemical pharmacology.

[74]  J. Hoeschele,et al.  Kinetic analysis of the in vitro binding of radioactive cis- and trans-dichlorodiammineplatinum(II) to DNA. , 1980, Chemico-biological interactions.

[75]  W. Sundquist,et al.  Binding of cis- and trans-diamminedichloroplatinum(II) to deoxyribonucleic acid exposes nucleosides as measured immunochemically with anti-nucleoside antibodies. , 1986, Biochemistry.

[76]  G. W. Bushnell,et al.  Purine complexes of platinum: synthesis, nmr, and crystal and molecular structures of cis-chloro(caffeine)bis(triethylphosphine)platinum(II) fluoroborate and cis-bis(isocaffeine)bis(triethylphosphine)platinum (II) fluoroborate , 1983 .

[77]  M. Krauss,et al.  Comparison of direct and through-water binding of platinum ammines to the phosphate anion , 1988 .

[78]  J. Dabrowiak,et al.  Platinum antitumour agents. , 1987, Progress in medicinal chemistry.

[79]  R. Brubaker,et al.  Effect of cis-Platinum(II)Diamminodichloride on Wild Type and Deoxyribonucleic Acid Repair-Deficient Mutants of Escherichia coli , 1973, Journal of bacteriology.

[80]  W. Sundquist,et al.  Solvolysis reactions of cis- And trans-diamminedichloroplatinum (II) in dimethyl sulfoxide. Structural characterization and DNA binding of trans-[Pt(NH3)2(Me2SO)Cl]+ , 1987 .

[81]  A. Oosterom,et al.  Platinum amine coordination compounds as anti-tumor drugs. Molecular aspects of the mechanism of action , 1987 .

[82]  G. Sava,et al.  Antineoplastic activity and toxicity of an organometallic complex of ruthenium(II) in comparison with cis-PDD in mice bearing solid malignant neoplasms. , 1984, European journal of cancer & clinical oncology.

[83]  G. A. van der Marel,et al.  cis-diamminedichloroplatinum(II) induced distortion of a single and double stranded deoxydecanucleosidenonaphosphate studied by nuclear magnetic resonance. , 1985, Journal of biomolecular structure & dynamics.

[84]  K. Inagaki,et al.  DETERMINATION OF PLATINUM BINDING BASES BY ENZYMATIC DIGESTION , 1983 .

[85]  L. Marzilli,et al.  Interaction of platinum antitumor agents with guanine nucleosides and nucleotides. Platinum-195 and proton NMR spectroscopic characterization of compound III , 1985 .

[86]  B. Keppler,et al.  Synthesis, antitumor activity, and X-ray structure of bis(imidazolium) (Imidazole)pentachlororuthenate(III), (ImH)2(RuImCl5) , 1987 .

[87]  C. Dorai,et al.  Synthesis and spectral studies on palladium and platinum complexes with mono- and bidentate N-donor organic ligands and their interaction with calf thymus DNA in solution☆ , 1985 .

[88]  K. S. Andersen.  Platinum(II) complexes generate frame-shift mutations in test strains of Salmonella typhimurium. , 1979, Mutation research.

[89]  S. Lippard,et al.  Structural aspects of platinum anticancer drug interactions with DNA , 1987 .

[90]  S. Lippard,et al.  The antitumor drug cis-dichlorodiammineplatinum forms an intrastrand d(GpG) crosslink upon reaction with [d(ApGpGpCpCpT)]2 , 1982 .

[91]  A. Peters,et al.  Reaction products from platinum(IV) amine compounds and 5'-GMP are mainly bis(5'-GMP)platinum(II) amine adducts. , 1986, Journal of inorganic biochemistry.

[92]  Z. Siddik,et al.  Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function. , 1984, Cancer research.

[93]  M. Kanatzidis,et al.  Metallocene antitumor agents. Unusual Mo(η5-C5H5)2Cl2 nucleotide/nucleobase aqueous coordination chemistry , 1987 .

[94]  Y. Qu,et al.  Structure, activity and mode of action of antitumor platinum compounds , 1988 .

[95]  C. Rawlings,et al.  Increased sensitivity of UV-repair-deficient human cells to DNA bound platinum products which unlike thymine dimers are not recognized by an endonuclease extracted from Micrococcus luteus. , 1978, Mutation research.

[96]  A. Marcelis,et al.  Rotation and conformation of purine ligands in cis-bis(6-oxopurine)-platinum compounds , 1983 .

[97]  J. Trosko,et al.  Platinum Compounds: a New Class of Potent Antitumour Agents , 1969, Nature.

[98]  S. Lippard,et al.  Sequence dependent binding of cis-dichlorodiammineplatinum(II) to DNA , 1980 .

[99]  R. Viola,et al.  Multinuclear NMR studies and the kinetics of formation of platinum(II)-adenine nucleotide complexes , 1986 .

[100]  S. Pizzo,et al.  cis-dichlorodiammineplatinum (II) as a selective modifier of the oxidation-sensitive reactive-center methionine in alpha 1-antitrypsin. , 1988, The Journal of biological chemistry.

[101]  B. Rosenberg,et al.  Syntheses, kinetics, and mechanism of formation of polynuclear hydroxo-bridged complexes of (trans-1,2-diaminocyclohexane)platinum(II) , 1982 .

[102]  A. Eastman.  Characterization of the adducts produced in DNA by cis-diamminedichloroplatinum(II) and cis-dichloro(ethylenediamine)platinum(II). , 1983, Biochemistry.

[103]  T. Hambley,et al.  Macrochelate complexes of purine 5'-nucleotide triphosphates and monophosphates: definitive multinuclear NMR evidence supported by molecular mechanics calculations , 1988 .

[104]  G. Petsko,et al.  High-salt and low-salt models for kinked adducts of cis-diamminedichloroplatinum(II) with oligonucleotide duplexes , 1986 .

[105]  S. Lippard,et al.  In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein cross-linking, and inhibition of replication. , 1985, Biochemistry.

[106]  J. Macquet,et al.  Crystal structures of diammine(oxalato)platinum(II)and diammine(malonato)platinum(II) , 1985 .

[107]  K. Alitalo,et al.  myc oncogenes: activation and amplification. , 1987, Biochimica et biophysica acta.

[108]  J. Lallemand,et al.  Interaction of cis-[Pt(NH3)2(H2O)2](NO3)2 with ribose deoxyribose diguanosine phosphates. , 1982, Biochemistry.

[109]  M. J. Ehrke,et al.  The effects of dichloro-trans-dihydroxy-bis-isopropyl-amine-platinum IV on the primary cell-mediated cytotoxic response. , 1983, Immunopharmacology.

[110]  H. C. Harder,et al.  Template primer inactivation by cis- and trans-dichlorodiammine platinum for human DNA polymerase alpha, beta, and Rauscher murine leukemia virus reverse transcriptase, as a mechanism of cytotoxicity. , 1976, Cancer research.

[111]  C. Matthews,et al.  Mutagenic and toxic effects of ruthenium. , 1980, Chemico-biological interactions.

[112]  S. Lippard,et al.  Site-specifically platinated DNA, a new probe of the biological activity of platinum anticancer drugs , 1986 .

[113]  G. A. van der Marel,et al.  cis-Platinum induced distortions in DNA. Conformational analysis of d(GpCpG) and cis-pt(NH3)2[d(GpCpG)], studied by 500-MHz NMR. , 1983, European journal of biochemistry.

[114]  A. E. Mihkelson,et al.  Metal chelates of biologically important compounds. II. Nickel complexes of dialkyldithiophosphates and their adducts with nitrogen heterocycles , 1970 .

[115]  E. Guittet,et al.  Chelation of the cis-PtII(NH3)2 moiety by the guanines of the oligonucleotides d(T-G-G-C-C-A), d(A-T-G-G) and d(C-C-A-T-G-G) , 1983 .

[116]  W. Scovell,et al.  cis-Diamminedichloroplatinum(II) selectively cross-links high mobility group proteins 1 and 2 to DNA in micrococcal nuclease accessible regions of chromatin. , 1987, Biochemical and biophysical research communications.

[117]  K. Inagaki,et al.  Differences in binding of (1,2-cyclohexanediamine)platinum(II) isomers with d(GpG) , 1986 .

[118]  E. Alessio,et al.  Reaction of cis-RuII(DMSO)4Cl2 with DNA and with some of its bases in aqueous solution , 1987 .

[119]  K. Inagaki,et al.  Bulky ligand substituent effect on the reaction of 5'-GMP with platinum-1,3-diamine. Rotation of 5'-GMP about the platinum-nitrogen bond and kinetic effects , 1988 .

[120]  G. Petsko,et al.  Molecular mechanics calculations on cis ([Pt(NH3)2{d(GpG)}] adducts in two oligonucleotide duplexes , 1985 .

[121]  J. Pitha.  Reagents specific for cell surface components. , 1978, European journal of biochemistry.

[122]  N. Katsaros,et al.  The interaction of the ruthenium(III)-chloride system with DNA , 1986 .

[123]  S. B. Prasad,et al.  Effect of cis-dichlorodiammine platinum(II) on the agglutinability of tumor and normal cells with concanavalin A and wheat germ agglutinin. , 1981, Chemico-biological interactions.

[124]  H. Elst,et al.  Reaction of the antitumor drug cis-diamminedichloroplatinum(II) with the trinucleotide d(GpApG): identification of the two main products and kinetic aspects of their formation , 1986 .

[125]  Dall Jl,et al.  MORE ACID/BASE DISTURBANCES. , 1963 .

[126]  A. Eastman.  Comparison of the interaction of cis- and trans-diamminedichloroplatinum(II) with DNA by a simple filter binding assay. , 1982, Biochemical and biophysical research communications.

[127]  J. Macquet,et al.  Viscosity, nicking, thermal and alkaline denaturation studies on three classes of DNA-platinum complex. , 1981, Biochimica et biophysica acta.

[128]  G. A. van der Marel,et al.  A 1H and 31P NMR study of cis-Pt(NH3)2[d(CpGpG)-N7(2),N7(3)]. The influence of a 5'-terminal cytosine, on the structure of the cis-Pt(NH3)2[d(GpG)-N7,N7] intrastrand cross-link. , 1985, European journal of biochemistry.

[129]  A. Marcelis,et al.  The interactions of cis- and trans-diammineplatinum compounds with 5′-guanosine monophosphate and 5′-deoxyguanosine monophosphate. A proton nmr investigation , 1980 .

[130]  M. Summers,et al.  HMQC and proton and phosphorus-31 NMR studies of platinum amMine adducts of tetradeoxyribonucleotides. Relationship between phosphorus-31 shift and potential hydrogen-bonding interactions in pGpG moieties cross-linked by platinum , 1988 .

[131]  A. Spek,et al.  The synthesis and characterization of 1,1-bis(aminomethyl)cyclohexaneplatinum(II) compounds and the crystal structure determination of 1,1-bis(aminomethyl)-cyclohexaneaquosulphatoplatinum(II) monohydrate , 1986 .

[132]  J. H. Boom,et al.  DNA strand scission by bleomycin: catalytic cleavage and strand selectivity , 1986 .

[133]  A Klug,et al.  A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. , 1977, Journal of molecular biology.

[134]  S. Lippard,et al.  cis-Diamminedichloroplatinum(II) binds in a unique manner to oligo(dG).oligo(dC) sequences in DNA - a new assay using exonuclease III , 1981 .

[135]  S. Mansy,et al.  Binding of cis- and trans-dichlorodiammineplatinum(II) to nucleosides. I. Location of the binding sites. , 1973, Journal of the American Chemical Society.

[136]  P. Umapathy,et al.  Synthesis and spectral studies on platinum complexes with mono- and bidentate N-donor organic ligands☆ , 1983 .

[137]  B. Barlogie,et al.  Effects of cis-dichlorodiammineplatinum(II) on human colon carcinoma cells in vitro. , 1979, Cancer research.

[138]  W. Sundquist,et al.  Monoclonal antibodies to DNA modified with cis- or trans-diamminedichloroplatinum(II). , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[139]  H. Gray,et al.  Chemical and biological properties of pentaammineruthenium-bleomycin complexes. , 1986, Chemico-biological interactions.

[140]  S. Lippard,et al.  Use of antibodies to probe the stereochemistry of antitumor platinum drug binding to deoxyribonucleic acid , 1983 .

[141]  S. Lippard,et al.  Synthesis and characterization of [d(ApGpGpCpCpT)]2 and its adduct with the anticancer drug cis-diamminedichloroplatinum(II) , 1988 .

[142]  A. Zipp,et al.  Pt(NH3)2Cl2 and cancer. An old compound with a new use. , 1977, Journal of chemical education.

[143]  J. Reedijk.  The mechanism of action of platinum antitumor drugs , 1987 .

[144]  A. Eastman.  Separation and characterization of products resulting from the reaction of cis-diamminedichloroplatinum (II) with deoxyribonucleosides. , 1982, Biochemistry.

[145]  J. Vollano,et al.  Synthesis and structure of dinuclear complexes of platinum(IV) having cis-diamine geometry , 1986 .

[146]  V. Brabec,et al.  DNA modified by platinum derivatives cannot adopt the A-form. , 1986, Biochimica et biophysica acta.

[147]  C. Rawlings,et al.  The role of DNA repair in the recovery of human cells from cisplatin toxicity. , 1981, Chemico-biological interactions.

[148]  Y. Lu,et al.  Properties of amino acid transport systems in K562 cells sensitive and resistant to cis-diamminedichloroplatinum(II). , 1986, Cancer research.

[149]  A. Thomson,et al.  Tracer Studies to Locate the Site of Platinum Ions Within Filamentous and Inhibited Cells of Escherichia coli , 1967, Journal of bacteriology.

[150]  T. Thomas,et al.  Hexammineruthenium (III) chloride: a highly efficient promoter of the B-DNA to Z-DNA transition of poly-(dG-m5dC).poly(dG-m5dC) and poly(dG-dC).poly(dG-dC). , 1988, Biochimie.

[151]  A. Eastman.  Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes. , 1987, Chemico-biological interactions.

[152]  V. Peyrot,et al.  NMR studies of the interaction of cis-diamminedichloro-platinum(II) and corresponding hydrolysis products with adenosine phosphates , 1986 .

[153]  A. Wang,et al.  X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]. , 1985, Science.

[154]  M. Summers,et al.  A new approach for assigning phosphorus-31 NMR signals and correlating adjacent nucleotide deoxyribose moieties via proton-detected multiple-quantum NMR. Application to the adduct of d(TGGT) with the anticancer agent (ethylenediamine)dichloroplatinum. , 1986, Journal of the American Chemical Society.

[155]  A. Rich,et al.  The interactions of ruthenium hexaammine with Z-DNA: crystal structure of a Ru(NH3)6+3 salt of d(CGCGCG) at 1.2 A resolution. , 1987, Journal of biomolecular structure & dynamics.

[156]  David R. Williams.  Anticancer drug design involving complexes of amino-acids and metal ions , 1972 .

[157]  B. Rosenberg,et al.  Crystal and molecular structure of bis(.mu.-(1-methyluracilato-N3,O4))-bis(cis-diammineplatinum(II)) dinitrate trihydrate, [(NH3)2Pt(C5H5N2O2)2Pt(NH3)2](NO3)2.3H2O , 1981 .

[158]  S. Lippard.  Platinum complexes: probes of polynucleotide structure and antitumor drugs , 1978 .

[159]  J. Hoeschele,et al.  Adducts formed between deoxyguanosine and cis-Dichlorodiammineplatinum(II): Separation by means of cation-exchange chromatography , 1983 .

[160]  M. J. Cleare,et al.  Transition metal complexes in cancer chemotherapy , 1974 .

[161]  David J Evans,et al.  The rate of reduction of cis-, cis-, trans-[PtIV(NH2Pri)2Cl2(OH)2], CHIP, the anti-cancer drug by ascorbic acid , 1987 .

[162]  K. Marx,et al.  Biochemical effects of binding [(H2O)(NH3)5RuII]2+ to DNA and oxidation to[(NH3)5RuIII]n—DNA. , 1986 .

[163]  V. Vonka,et al.  Inactivation of papovavirus SV 40 by cis-dichlorodiammine platinum(II). , 1972, Neoplasma.

[164]  BARNETT ROSENBERG,et al.  Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode , 1965, Nature.

[165]  W. Gilbert,et al.  Sequencing end-labeled DNA with base-specific chemical cleavages. , 1980, Methods in enzymology.

[166]  S. Lippard,et al.  Synthesis and NMR structural studies of the adduct of trans-diamminedichloroplatinum(II) with the DNA fragment d(GpCpG) , 1987 .

[167]  A. Laoui,et al.  Sequence-dependent platinum chelation by adenylyl(3'-5')guanosine and guanylyl(3'-5')adenosine reacting with cis-diamminedichloroplatinum(II) and its diaqua derivative , 1987 .

[168]  J. Roberts,et al.  Cross-linking of Complementary Strands of DNA in Mammalian Cells by Antitumour Platinum Compounds , 1972, Nature.

[169]  H. Halvorson,et al.  Resolution of α, β and γ DNA of Saccharomyces cerevisiae with the antitumor drug cis-Pt(NH3)2Cl2. Evidence for preferential drug binding by GpG sequences of DNA , 1976 .

[170]  G. Sava,et al.  Coordination metal complexes of Rh(I), Ir(I) and Ru(II): recent advances on antimetastatic activity on solid mouse tumors , 1987 .

[171]  D. Barnes,et al.  A comparative study of the cytotoxicity and DNA-damaging effects of cis-(diammino)(1,1-cyclobutanedicarboxylato)-platinum(II) and cis-diamminedichloroplatinum(II) on L1210 cells. , 1985, Cancer research.

[172]  A. Spek,et al.  Synthesis and characterization of antitumor-active platinum 2,2-dimethyl-1,3-diaminopropane compounds. Crystal and molecular structure of (malonato)(2,2-dimethyl-1,3-diaminopropane)platinum(II) , 1980 .

[173]  B. Hill,et al.  Differential repair of platinum-DNA adducts in human bladder and testicular tumor continuous cell lines. , 1988, Cancer research.

[174]  W. J. Stevens,et al.  A theoretical model for the binding of cis-Pt(NH3)2(+2) to DNA. , 1985, Journal of biomolecular structure & dynamics.

[175]  P. Keng,et al.  Effect of diethyldithiocarbamate on cis-diamminedichloroplatinum(II)-induced cytotoxicity, DNA cross-linking, and gamma-glutamyl transpeptidase inhibition. , 1986, Cancer research.

[176]  G. Petsko,et al.  Molecular mechanics modeling of oligonucleotide adducts of the antitumor drug cis‐diamminedichloroplatinum(II) , 1987, Biopolymers.

[177]  K. Kohn,et al.  Mutagenicity, cytotoxicity and DNA crosslinking in V79 Chinese hamster cells treated with cis- and trans-Pt(II) diamminedichloride. , 1979, Mutation research.

[178]  P. van de Putte,et al.  Base-pair substitution hotspots in GAG and GCG nucleotide sequences in Escherichia coli K-12 induced by cis-diamminedichloroplatinum (II). , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[179]  G. Gale,et al.  Cis-dichlorodiammineplatinum (II). Persistent and selective inhibition of deoxyribonucleic acid synthesis in vivo. , 1970, Biochemical pharmacology.